Baseline BCVA, NEI-VFQ 25 and MacTSQ subscale scores by gender
| All N=110 | Male N=78 | Female N=32 | Mean difference | P value | 95% CI | |
| Age (years) | 63.8 | 63.4 | 64.7 | −1.3 | 0.51 | −5.4 to 2.7 |
| BCVA of study eye (letters) | 62.8 | 63.8 | 60.5 | 3.5 | 0.18 | 1.5 to 8.0 |
| NEI-VFQ 25 GH | 49.3 | 49.7 | 48.4 | 1.24 | 0.81 | −8.9 to 11.4 |
| NEI-VFQ 25 GV | 42.4 | 43.1 | 40.6 | 2.49 | 0.53 | −5.3 to 10.3 |
| NEI-VFQ 25 OP | 79.4 | 80.4 | 77.0 | 3.50 | 0.48 | −6.3 to 13.3 |
| NEI-VFQ 25 NA | 56.4 | 59.5 | 49.0 | 10.55 | 0.06 | −0.23 to 21.3 |
| NEI-VFQ 25 DA | 67.0 | 70.8 | 57.8 | 13.02 | 0.02 | 2.0 to 24.0 |
| NEI-VFQ 25 CV | 88.3 | 89.6 | 85.2 | 4.45 | 0.32 | −4.5 to 13.4 |
| NEI-VFQ 25 PV | 76.8 | 78.8 | 71.8 | 7.07 | 0.20 | −3.7 to 17.8 |
| NEI-VFQ 25 SF | 79.7 | 79.3 | 80.5 | −1.14 | 0.83 | −11.8 to 9.5 |
| NEI-VFQ 25 MH | 54.1 | 54.7 | 52.5 | 2.19 | 0.72 | −9.9 to 14.2 |
| NEI-VFQ 25 RD | 59.7 | 60.7 | 57.4 | 3.27 | 0.62 | −9.7 to 16.2 |
| NEI-VFQ 25 D | 74.7 | 75.9 | 71.9 | 3.99 | 0.54 | −9.0 to 17.0 |
| NEI-VFQ 25 DR | 60.4 | 61.0 | 58.3 | 2.69 | 0.80 | −19.6 to 23.9 |
| NEI-VFQ 25 composite | 67.5 | 4.91 | 0.28 | −4.1 to 13.9 | ||
| MacTSQ subscale 1* | 33.3 | 33.0 | 33.9 | −0.88 | 0.20 | −2.2 to 0.5 |
| MacTSQ subscale 2† | 28.9 | 29.3 | 27.9 | 1.41 | 0.18 | −0.6 to 3.5 |
*Information provision and convenience.
†Impact of treatment and satisfaction.
BCVA, best-corrected visual acuity; CV, colour vision;D, dependency;DA, distance activity;DR, driving; GH, general health;GV, general vision;MH, mental health;NA, near activity;NEI-VFQ, National Eye Institute Visual Function Questionnaire; OP, ocular pain;PV, peripheral vision;RD, role difficulty;SF, social functioning.